News

A delegation from the National Evidence-based Healthcare Collaborating Agency (NECA) in the Republic of South Korea was here on May 7 to learn more about the regulation and assessment of medical devices in Canada. CADTH signed a memorandum of understanding with NECA to work together on advancing health technology assessment (HTA) in Canada and S...

Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

CADTH is hosting a series of lectures by prominent scholars and opinion leaders to share their perspectives on some of the most pressing issues facing health technology assessment (HTA) and health care today. After a successful webinar hosted live from the CADTH Symposium, we will resume our regular schedule and invite you to attend the next lec...

In January 2012 CADTH outlined our process for undertaking Therapeutic Reviews in a Therapeutic Review Framework. Today we have updated this framework to clarify the timing and scope of these reviews, as well as the type of evidence that is considered. These changes are outlined in more detail below. Revised Therapeutic Review Framework: Definit...

We are pleased to announce the appointment of Brent Fraser to the position of Vice-President, Pharmaceutical Reviews, effective August 4, 2015. In this role, Brent will be responsible for the CADTH Common Drug Review, the pan-Canadian Oncology Drug Review, and all other aspects of CADTH work in the pharmaceutical space. Brent joins CADTH from th...